Medical device commercialization (SME Instrument pathway)
3 European H2020 organizations list this as part of their work.
Most active in this area
- LIGHTSENSE TECHNOLOGIES LTD
London medtech SME developing laser-based medical devices for pigmentation disorder treatment in aesthetic dermatology.
“LightSense completed the full SME Instrument Phase 1 → Phase 2 pipeline, a progression achieved by fewer than 15% of Phase 1 applicants.”
SMEUK2 projects - NEWPACE LTD
Israeli medtech SME developing a miniaturized implantable subcutaneous defibrillator for sudden cardiac death prevention.
“Successfully completing both SME-1 feasibility and SME-2 full-development phases demonstrates capability in EU-funded product development and regulatory-pathway navigation.”
SMEIL2 projects - CARMEL DIAGNOSTICS LTD
Israeli MedTech SME developing Fertissimo, an oxidative stress diagnostic system for embryo selection in IVF fertility treatment.
“Carmel successfully completed the full SME Instrument two-phase pathway — Phase 1 feasibility (€50K) followed by Phase 2 full development (€1.4M) — demonstrating ability to take a technology from concept to market-ready product within EU frameworks.”
SMEIL2 projects